Gene · 1311
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic profiling of prostate cancer reveals molecular signatures under antiandrogen treatment. | Clin Proteomics | 2024 | 38918720 | PubTator, text mining | PubMed |
| Metformin as adjuvant therapy in obese knee osteoarthritis patients. | Inflammopharmacology | 2024 | 38869746 | PubTator, text mining | PubMed |
| KDM3A knockdown regulates COMP, LOX, COL8A1 and ACOT1 genes in myocardial fibrosis. | Bioinformation | 2024 | 38854759 | PubTator, text mining | PubMed |
| Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis. | Bone Joint Res | 2024 | 38826065 | PubTator, text mining | PubMed |
| Cartilage Oligomeric Matrix Protein in Osteoarthritis and Obesity-Do New Considerations Emerge? | Int J Mol Sci | 2024 | 38791302 | PubTator, text mining | PubMed |
| Interactions of cumulative load with biomarkers of cartilage turnover predict knee cartilage change over 2 years: data from the osteoarthritis initiative. | Clin Rheumatol | 2024 | 38787477 | PubTator, text mining | PubMed |
| Structure-Dependent Water Responsiveness of Protein Block Copolymers. | ACS Appl Bio Mater | 2024 | 38748757 | PubTator, text mining | PubMed |
| A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers. | Rheumatol Ther | 2024 | 38662148 | PubTator, text mining | PubMed |
| Engineered coiled-coil HIF1α protein domain mimic. | Biomater Sci | 2024 | 38656316 | PubTator, text mining | PubMed |
| Testing a candidate composite serum protein marker of skin severity in systemic sclerosis. | Rheumatol Adv Pract | 2024 | 38645474 | PubTator, text mining | PubMed |
| Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition. | J Transl Med | 2024 | 38615020 | PubTator, text mining | PubMed |
| The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma. | Cancer Immunol Immunother | 2024 | 38563861 | PubTator, text mining | PubMed |
| Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration. | Eur J Med Res | 2024 | 38528617 | PubTator, text mining | PubMed |
| The molecular mechanism of thrombospondin family members in cardiovascular diseases. | Front Cardiovasc Med | 2024 | 38516004 | PubTator, text mining | PubMed |
| COMP promotes pancreatic fibrosis by activating pancreatic stellate cells through CD36-ERK/AKT signaling pathways. | Cell Signal | 2024 | 38479555 | PubTator, text mining | PubMed |
| Genetically Encoded XTEN-based Hydrogels with Tunable Viscoelasticity and Biodegradability for Injectable Cell Therapies. | Adv Sci (Weinh) | 2024 | 38477407 | PubTator, text mining | PubMed |
| Stromal cell-derived factor 1 alpha (SDF-1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy. | Int J Rheum Dis | 2024 | 38465833 | PubTator, text mining | PubMed |
| Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease. | Medicina (Kaunas) | 2024 | 38399592 | PubTator, text mining | PubMed |
| Modifying loading during gait leads to biochemical changes in serum cartilage oligomeric matrix protein concentrations in a subgroup of individuals with anterior cruciate ligament reconstruction. | Clin Rheumatol | 2024 | 38358589 | PubTator, text mining | PubMed |
| Osteoarthritis versus psoriasis arthritis: Physiopathology, cellular signaling, and therapeutic strategies. | Genes Dis | 2024 | 38292181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1311/papers?page=6